Objective: The aim of the study is to review the oncological and surgical strategies for Wilms tumor (WT) with intravascular thrombus
extension at our institution.
Patients and Methods: Medical records of patients with WT treated in our institution between June 2012 and June 2024 were
retrospectively reviewed. Among these data, patients with intravascular tumor thrombus were identified. Demographics, imaging
studies to determine the initial level of thrombus, surgical management and outcomes were analyzed.
Results: During this period 51 patients with WT were treated in our institution. Seven patients (6 male, 1 female) with intravascular
tumor thrombus extension were identified (13%). The median age was 46 months (22-67 months). Six patients had unilateral WT
(UWT) and one patient had bilateral WT (BWT). Tumor thrombus extension during initial evaluation were: level III (5), level IV (1)
and level V (1). Thrombus level in all patients with level III regressed to level II, while, no regression was observed in 2 patients with
cardiac thrombus. All patients underwent surgery after neoadjuvant chemotherapy. At a median follow-up of 5 years, the 5-year eventfree
survival and overall survival rates were 83.3% and 83.3% respectively in patients with intravascular thrombus. In addition, the
5-year event-free survival and overall survival rates were 85% and 94% respectively in patients without intravascular thrombus.
Conclusion: Management of WT with intravascular thrombus is a challenging process. Multidisciplinary approach and an experienced
surgical team are the main factors that determine survival in these patients.
Birincil Dil | İngilizce |
---|---|
Konular | Cerrahi (Diğer) |
Bölüm | Original Research |
Yazarlar | |
Yayımlanma Tarihi | 30 Mayıs 2025 |
Gönderilme Tarihi | 25 Kasım 2024 |
Kabul Tarihi | 27 Aralık 2024 |
Yayımlandığı Sayı | Yıl 2025 Cilt: 38 Sayı: 2 |